Pancreatic Cancer
Pancreatic cancer (PC) is one of the most lethal malignancies. The disease is almost always detected when at an advanced stage, hence biomarkers to facilitate earlier disease detection, when there are greater opportunities for effective treatment, are urgently sought.
SERVICES
Biomarkers
Traditional Detection Tools
- CA19-9
- Imaging Diagnosis
- Abdominal Ultrasonography
- Contrast-enhanced CT
- MRI/MRCP
- EUS W/O FNA
- FDG-PET
Liquid biopsy and Bodily Fluids
Liquid Biopsy
cfDNA, CTCs and Exosomes.
Bodily Fluids
Fecal, Urinary and Salivary Biomarkers.
Novel Biomarkers
- Genetic,
- Epigenetic,
- ncRNA,
- Metabolomics,
- Microbiome and
- Proteomics.
Our approach
is a carefully validated, clinically realistic model for early diabetes mellitus screening and managing of the disease.
Our mathematical & computational tools
enable researchers and decision makers to make better informed decisions.
